Mather Group’s abrdn Healthcare Investors HQH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.75K Hold
419
– – ﹤0.01% 1683
2026
Q2
$9.21K Buy
419
+3
+0.7% +$59 ﹤0.01% 1520
2026
Q1
$7.4K Buy
+416
New +$7.87K ﹤0.01% 1518
2025
Q4
– Sell
-416
Closed -$7.68K – 1079
2025
Q3
$7.68K Buy
+416
New +$6.79K ﹤0.01% 1313
2025
Q2
– Sell
-416
Closed -$6.76K – 1093
2025
Q1
$6.76K Hold
416
– – ﹤0.01% 1346
2024
Q4
$6.68K Hold
416
– – ﹤0.01% 1327
2024
Q3
$7.75K Hold
416
– – ﹤0.01% 1216
2024
Q2
$7.01K Hold
416
– – ﹤0.01% 1538
2024
Q1
$6.89K Buy
+416
New +$7.09K ﹤0.01% 1286

Other funds holding HQH

Mather Group's HQH Position: Q3 2026 in Review

Mather Group held its abrdn Healthcare Investors (HQH) position steady in Q3 2026 at 419 shares worth $8.75K. The position accounts for ﹤0.01% of the portfolio, ranked #1683.

Mather Group first reported a position in HQH in Q1 2024 and has held it in 9 quarters since. The position peaked at $9.21K in Q2 2026. 27 funds tracked by Wall St. Rank hold HQH as of Q3 2026.

  • Mather Group held 419 shares of abrdn Healthcare Investors worth $8.75K as of Q3 2026.
  • Mather Group left its abrdn Healthcare Investors share count unchanged in Q3 2026.
  • abrdn Healthcare Investors made up ﹤0.01% of Mather Group's portfolio in Q3 2026, its #1683 holding.
  • Mather Group first reported a position in abrdn Healthcare Investors in Q1 2024 and has held it in 9 quarters since.
  • Mather Group's abrdn Healthcare Investors position peaked at $9.21K in Q2 2026.
  • 27 funds tracked by Wall St. Rank held abrdn Healthcare Investors as of Q3 2026.

Based on Mather Group's 13F filing for Q3 2026, filed 14 Oct 2026.